RT Journal Article
SR Electronic
T1 Impact of sensitive circulating tumor DNA monitoring on CT scan intervals during postoperative colorectal cancer surveillance
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.03.22279571
DO 10.1101/2022.09.03.22279571
A1 Sasaki, Tomoko
A1 Iwaya, Takeshi
A1 Yaegashi, Mizunori
A1 Idogawa, Masashi
A1 Hiraki, Hayato
A1 Abe, Masakazu
A1 Koizumi, Yuka
A1 Sasaki, Noriyuki
A1 Yashima-Abo, Akiko
A1 Fujisawa, Ryosuke
A1 Endo, Fumitaka
A1 Tange, Shoichiro
A1 Hirano, Tomomi
A1 Otsuka, Koki
A1 Sasaki, Akira
A1 Masuda, Mari
A1 Fujita, Masashi
A1 Nakagawa, Hidewaki
A1 Takahashi, Fumiaki
A1 Sasaki, Yasushi
A1 Tokino, Takashi
A1 Nishizuka, Satoshi S.
YR 2023
UL http://medrxiv.org/content/early/2023/10/25/2022.09.03.22279571.abstract
AB Objective This study investigated whether digital PCR (dPCR)-based circulating tumor DNA (ctDNA) monitoringcan allow longer intervals between computed tomography (CT) scans during postoperative surveillance of colorectal cancer (CRC).Design The longitudinal dynamics of ctDNA for 52 patients with CRC as measured by dPCR using probes targeting 87 individual tumor-specific mutations (1-5 per patient) were compared with results from conventional (i.e., clinical) surveillance using serum tumor markers and CT. A total of 382 CT procedures were carried out for the patient cohort (3.3/year per patient) and the median lead time from ctDNA relapse to clinical relapse was 182 days (range 0-376 days). If the CT interval was annual, potential delays in detection of clinical relapse would have occurred for 7 of the 10 patients who experienced clinical relapse (9 of 13 events), with a median delay of 164 days (range, 0-267 days). If annual CT surveillance was performed together with ctDNA monitoring, 218 (57.1%) CTs would not have been needed to detect the first clinical relapse. Nonetheless, ctDNA monitoring would still have provided a lead time of 339 days for detection of clinical relapse (range, 42-533 days).Conclusion Our findings suggest that the ctDNA monitoring as part of post-operative surveillance and clinical relapse detection for patients with CRC could allow the CT interval to be lengthened.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialUMIN Clinical Trial Registry number, UMIN000045114Funding StatementThis work was supported by a Grant-in-Aid for Scientific Research KAKENHI [16K19951, 16K19952, 16H06279, 17K10605, 19K09224, 20K09064, 20K08966, and 21K07223], Keiryokai Collaborative Research Grant [#136 and #145], and Iwate Prefectural Research Grants [H30, R2, and R3]Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board of Iwate Medical University (IRB #HGH28-15 and #MH2021-073).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.